Project Grant R21DA062182
Award Date
9/30/24
Completion Date
9/29/26
Dollars Obligated
$459K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Santa Monica, CA 90401, USA
Similar Awards
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to examine the relationship between opioid use disorder (OUD) and cardiovascular disease (CVD) risk, as well as assess the impact of Medicaid Health Home models on CVD risk reduction among people with OUD. Specifically, the $189,500 award will support research to: 1) Examine the relationship between OUD and time to major adverse cardiovascular events...
This federal Project Grant award, with a total funding amount of $2,542,500.00, was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The award supports the development of novel econometric research methods and a unified framework to integrate real-world evidence (RWE) into the analysis of inconclusive randomized controlled trials (RCTs) for opioid use disorder (OUD) treatments. This innovative approach aims to enhance the...
The National Institute on Drug Abuse (NIDA) awarded a $564,326 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to The Trustees of Columbia University in the City of New York, Health Sciences Division. The project, titled "Leveraging Harmonized Data to Improve External Validity and Efficiency of Clinical Trials for Treating Opioid Use Disorder," aims to develop new statistical methods for combining data from multiple clinical trials to enhance the power...
This $1,377,306 Project Grant award from the National Institute on Drug Abuse (NIDA), under the Federal Grant Program "Drug Use and Addiction Research Programs" (CFDA 93.279), will fund a multi-jurisdictional study aimed at transforming the evidence base on the prevalence of opioid use disorder (OUD) and the impact of opioid agonist treatment (OAT) in preventing opioid-related deaths. The study will leverage data linkages across sites in the U.S. (Rhode Island, Wisconsin, Colorado, and...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $106,714 to support a dissertation project examining the impact of the criminal legal system on opioid use disorder (OUD) treatment and recovery. The key objectives of the project are to: 1) Analyze the influence of the criminal legal system on the language used to discuss OUD treatment and recovery in high-impact communities, 2) Assess the...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will assess the impact of New York State's Medicaid Value-Based Payment (VBP) policy on outcomes related to opioid use disorder (OUD), including service utilization, quality of care, overdose, and healthcare costs. The $1,329,844 award, with a performance period from August 1, 2024 to May 31, 2029, will leverage a natural experiment to determine the overall...
This $1,192,612 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to integrate HIV prevention services into clinical care settings for people with opioid use disorder (OUD). The key objectives are to: Conduct a systematic assessment of healthcare utilization, HIV prevention services, and medication for OUD using claims and emergency department data (Specific Aim 1). Use an evidence-based quality...
This $4,112,069 Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will support a mixed-methods study to examine the effects of Medicaid Managed Care Organization (MCO) entries and exits on provider networks, quality of care, and health care utilization for Medicaid enrollees with substance use disorders. The study will use national Medicaid data to investigate these effects using a difference-in-differences...
The National Institute on Drug Abuse (NIDA) awarded a $424,545 Project Grant (CFDA 93.279 - Drug Use and Addiction Research Programs) to the RAND Corporation to conduct a national survey on naloxone use and access in the United States. The grant will fund two surveys over the project period from September 2024 to August 2026. One survey will collect data from a nationally-representative online sample, while the other will survey individuals self-reporting opioid dependence. The goal is to gather...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to integrate patient social risk information into an existing electronic health record-based clinical decision support (CDS) tool. The goal is to facilitate emergency department-initiated, social risk-informed opioid use disorder (OUD) medication treatment and improve treatment adherence and follow-up. Awarded to the Regents of the University of...